BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

365 related articles for article (PubMed ID: 21488084)

  • 21. Alpha-Synuclein is Involved in DYT1 Dystonia Striatal Synaptic Dysfunction.
    Ponterio G; Faustini G; El Atiallah I; Sciamanna G; Meringolo M; Tassone A; Imbriani P; Cerri S; Martella G; Bonsi P; Bellucci A; Pisani A
    Mov Disord; 2022 May; 37(5):949-961. PubMed ID: 35420219
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Differential electrophysiological changes in striatal output neurons in Huntington's disease.
    André VM; Cepeda C; Fisher YE; Huynh M; Bardakjian N; Singh S; Yang XW; Levine MS
    J Neurosci; 2011 Jan; 31(4):1170-82. PubMed ID: 21273402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Dopamine receptor agonists reverse behavioral abnormalities of alpha-synuclein transgenic mouse, a new model of Parkinson's disease.
    Wakamatsu M; Iwata S; Funakoshi T; Yoshimoto M
    J Neurosci Res; 2008 Feb; 86(3):640-6. PubMed ID: 17896793
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mice lacking alpha-synuclein display functional deficits in the nigrostriatal dopamine system.
    Abeliovich A; Schmitz Y; Fariñas I; Choi-Lundberg D; Ho WH; Castillo PE; Shinsky N; Verdugo JM; Armanini M; Ryan A; Hynes M; Phillips H; Sulzer D; Rosenthal A
    Neuron; 2000 Jan; 25(1):239-52. PubMed ID: 10707987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dopamine D2 receptor activation potently inhibits striatal glutamatergic transmission in a G2019S LRRK2 genetic model of Parkinson's disease.
    Tozzi A; Durante V; Bastioli G; Mazzocchetti P; Novello S; Mechelli A; Morari M; Costa C; Mancini A; Di Filippo M; Calabresi P
    Neurobiol Dis; 2018 Oct; 118():1-8. PubMed ID: 29908325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alterations in corticostriatal synaptic plasticity in mice overexpressing human alpha-synuclein.
    Watson JB; Hatami A; David H; Masliah E; Roberts K; Evans CE; Levine MS
    Neuroscience; 2009 Mar; 159(2):501-13. PubMed ID: 19361478
    [TBL] [Abstract][Full Text] [Related]  

  • 27. α-synuclein and synapsin III cooperatively regulate synaptic function in dopamine neurons.
    Zaltieri M; Grigoletto J; Longhena F; Navarria L; Favero G; Castrezzati S; Colivicchi MA; Della Corte L; Rezzani R; Pizzi M; Benfenati F; Spillantini MG; Missale C; Spano P; Bellucci A
    J Cell Sci; 2015 Jul; 128(13):2231-43. PubMed ID: 25967550
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased extracellular dopamine concentrations and FosB/DeltaFosB expression in striatal brain areas of heterozygous GDNF knockout mice.
    Airavaara M; Planken A; Gäddnäs H; Piepponen TP; Saarma M; Ahtee L
    Eur J Neurosci; 2004 Nov; 20(9):2336-44. PubMed ID: 15525275
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Alterations in the nigrostriatal system following conditional inactivation of α-synuclein in neurons of adult and aging mice.
    Ninkina N; Tarasova TV; Chaprov KD; Roman AY; Kukharsky MS; Kolik LG; Ovchinnikov R; Ustyugov AA; Durnev AD; Buchman VL
    Neurobiol Aging; 2020 Jul; 91():76-87. PubMed ID: 32224067
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Functional alterations of the dopaminergic and glutamatergic systems in spontaneous α-synuclein overexpressing rats.
    Guatteo E; Rizzo FR; Federici M; Cordella A; Ledonne A; Latini L; Nobili A; Viscomi MT; Biamonte F; Landrock KK; Martini A; Aversa D; Schepisi C; D'Amelio M; Berretta N; Mercuri NB
    Exp Neurol; 2017 Jan; 287(Pt 1):21-33. PubMed ID: 27771352
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson's disease model.
    Wegrzynowicz M; Bar-On D; Calo' L; Anichtchik O; Iovino M; Xia J; Ryazanov S; Leonov A; Giese A; Dalley JW; Griesinger C; Ashery U; Spillantini MG
    Acta Neuropathol; 2019 Oct; 138(4):575-595. PubMed ID: 31165254
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Heterosynaptic dopamine neurotransmission selects sets of corticostriatal terminals.
    Bamford NS; Zhang H; Schmitz Y; Wu NP; Cepeda C; Levine MS; Schmauss C; Zakharenko SS; Zablow L; Sulzer D
    Neuron; 2004 May; 42(4):653-63. PubMed ID: 15157425
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alpha-synuclein/synapsin III pathological interplay boosts the motor response to methylphenidate.
    Faustini G; Longhena F; Bruno A; Bono F; Grigoletto J; La Via L; Barbon A; Casiraghi A; Straniero V; Valoti E; Costantino G; Benfenati F; Missale C; Pizzi M; Spillantini MG; Bellucci A
    Neurobiol Dis; 2020 May; 138():104789. PubMed ID: 32032728
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pathological gamma oscillations, impaired dopamine release, synapse loss and reduced dynamic range of unitary glutamatergic synaptic transmission in the striatum of hypokinetic Q175 Huntington mice.
    Rothe T; Deliano M; Wójtowicz AM; Dvorzhak A; Harnack D; Paul S; Vagner T; Melnick I; Stark H; Grantyn R
    Neuroscience; 2015 Dec; 311():519-38. PubMed ID: 26546830
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Selective dopamine filter of glutamate striatal afferents.
    Dani JA; Zhou FM
    Neuron; 2004 May; 42(4):522-4. PubMed ID: 15157413
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Early synaptic dysfunction induced by α-synuclein in a rat model of Parkinson's disease.
    Phan JA; Stokholm K; Zareba-Paslawska J; Jakobsen S; Vang K; Gjedde A; Landau AM; Romero-Ramos M
    Sci Rep; 2017 Jul; 7(1):6363. PubMed ID: 28743955
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Regional and cell-type-specific effects of DAMGO on striatal D1 and D2 dopamine receptor-expressing medium-sized spiny neurons.
    Ma YY; Cepeda C; Chatta P; Franklin L; Evans CJ; Levine MS
    ASN Neuro; 2012 Mar; 4(2):. PubMed ID: 22273000
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased GABAergic transmission in neuropeptide Y-expressing neurons in the dopamine-depleted murine striatum.
    Rubi L; Fritschy JM
    J Neurophysiol; 2020 Apr; 123(4):1496-1503. PubMed ID: 32159408
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Region specific mitochondrial impairment in mice with widespread overexpression of alpha-synuclein.
    Subramaniam SR; Vergnes L; Franich NR; Reue K; Chesselet MF
    Neurobiol Dis; 2014 Oct; 70():204-13. PubMed ID: 25016198
    [TBL] [Abstract][Full Text] [Related]  

  • 40. G2019S LRRK2 mutation facilitates α-synuclein neuropathology in aged mice.
    Novello S; Arcuri L; Dovero S; Dutheil N; Shimshek DR; Bezard E; Morari M
    Neurobiol Dis; 2018 Dec; 120():21-33. PubMed ID: 30172844
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.